HEP therapy for motor and sensory development in infants with Down syndrome

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single‑site interventional study in Istanbul will enroll infants with Down syndrome and compare the HEP approach to traditional pediatric rehabilitation over 12 weekly 45‑minute sessions. Parents will provide informed consent and demographic and perinatal data will be collected. Outcomes include gross and fine motor skills (PDMS‑2), infant sensory function (BDFT), parent‑reported development (ASQ), individualized goals (GAS), and social validity by parent questionnaire. Participants will be recruited via social media and professional referrals to a private clinic in Beykoz.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Must be between 4 and 12 months old
* Must have been diagnosed with Down Syndrome
* Must not be at any neurological risk
* Parent must agree to participate regularly in the study process

Exclusion Criteria:

* History of intraventricular hemorrhage (Grade III or IV)
* Major vision or hearing impairment
* History of febrile convulsion
* Medical conditions (e.g., oxygen dependence) that prevent active participation in the study
* Participation in other experimental rehabilitation studies

Where it's running

• Sense On
  Istanbul, Beykoz, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: İzgi Miray Demirbağ, Physiotherapist
• Email: izgimiray@hotmail.com
• Phone: +905516626550

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Levetiracetam to prevent seizures in adults with Down syndrome and Alzheimer's disease

  This trial will test whether the anti-seizure medicine levetiracetam can prevent tonic-clonic seizures and slow cognitive decline in adults over 40 who have Down syndrome and symptomatic Alzheimer's disease.

  Recruiting Phase 3 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Granada, Andalusia and 4 other locations · NCT07234695

• Therapy plan for children with Down syndrome and acute myeloid leukemia in Russia

  This trial will test a standardized four-course chemotherapy program for children (0–18) with AML and Down syndrome in Russia to try to improve survival and reduce treatment side effects.

  Recruiting Phase 3 Federal Research Institute of Pediatric Hematology, Oncology and Immunology · Moscow · NCT07232134

• Epi-ON corneal crosslinking with UVA for people with Down syndrome and corneal ectasia

  This trial will try Epi-ON corneal crosslinking (riboflavin drops plus UVA light) to see if it can slow or stop corneal thinning and vision loss in people with Down syndrome who have keratoconus or similar ectatic corneal conditions.

  Recruiting at 12 sites Phase 3 Woolfson Eye Institute · Atlanta, Georgia and 11 other locations · NCT07135167

• Technology to promote healthy lifestyles in young people with intellectual disabilities

  This project will try a smartphone-based program with families and teachers to help children and young adults with intellectual disabilities move more and eat healthier.

  Recruiting University of Seville · Seville, Spain · NCT07101523

• Assessing Inspire therapy for adolescents with Down syndrome and severe sleep apnea

  This study is testing a new sleep therapy for teenagers with Down syndrome and severe sleep apnea to see if it helps them sleep better and improves their quality of life.

  Recruiting Inspire Medical Systems, Inc. · Phoenix, Arizona and 5 other locations · NCT06851338

• Effects of Suspension Therapy on Mobility and Balance in Children with Down Syndrome

  This study is testing if Suspension Therapy can help improve balance and mobility in young children with Down syndrome.

  Recruiting at 2 sites Riphah International University · Lahore, Punjab Province and 1 other locations · NCT06748248

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.